Laboratory Corp. of America Holdings

Laboratory Corporation of America Holdings is a life sciences company engaged in providing clinical laboratory and end-to-end drug development services. The company reports its business in two segments: LabCorp Diagnostics, which provides a menu of testing through an integrated network of primary and specialty laboratories across the U.S., supported by an information technology system, logistics, local labs providing testing, and also provides patient access points located throughout the U.S.; and Covance Drug Development, which provides end-to-end drug development, medical device and diagnostic development solutions from early-stage research to clinical development and commercial market access.
  • TickerLH
  • ISINUS50540R4092
  • ExchangeNew York Stock Exchange
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for LH

ValuEngine Rating and Forecast Report for LH

Laboratory Corp Of America Holdings: 1 director sold after exercising options/sold

A director at Laboratory Corp Of America Holdings sold after exercising options/sold 23,379 shares at 189.764USD and the significance rating of the trade was 86/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is ...

ValuEngine Rating and Forecast Report for LH

ValuEngine Rating and Forecast Report for LH

ValuEngine Rating and Forecast Report for LH

ValuEngine Rating and Forecast Report for LH

Moody's assigns Baa2 rating to LabCorp notes offering

Rating Action: Moody's assigns Baa2 rating to LabCorp notes offering. Global Credit Research- 19 Nov 2019. New York, November 19, 2019-- Moody's Investors Service assigned a Baa2 rating to the proposed offering of senior unsecured notes of Laboratory Corporation of America Holdings.

Laboratory Corporation of America Holdings: Update to credit analysis

LabCorp's credit profile is supported by the company's significant market presence and moderate leverage.

Laboratory Corporation of America Holdings: Update to credit analysis

LabCorp's credit profile is supported by the company's significant market presence and moderate leverage.

Moody's: LabCorp's Divestiture of Food Solutions Business is Credit Positive

Moody's Investors Service commented that the announcement by Laboratory Corporation of America Holdings ("LabCorp") to divest its Food Solutions business for $670 million is a credit positive. There is no impact on LabCorp's Baa2 ratings or stable outlook. For additional inform...

Laboratory Corporation of America Holdings: LabCorp's divestiture of Food Solutions business is credit positive

LabCorp's divestiture of Covance Food Solutions business will help in further reducing leverage.

Feasibility Study Results in December to be a Catalyst for this Junior

Feasibility Study Results in December to be a Catalyst for this Junior